Dexcom (DXCM) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Dexcom (DXCM) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Dexcom

· DXCM

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

32.695 B

-0.40%

General

Market Cap: $32.69B
Enterprise Value: $32.86B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 62.47%
Operating Margin: 22.92%
Net Profit Margin: 20.12%
FCF Margin: 28.27%
ROA: 15.49%
ROE: 36.19%
ROIC: 21.60%
Current Ratio: 1.73
Debt-to-Equity: 0.53
Revenue Per Employee: —

Valuation (TTM)

P/E: 33.12
PEG: —
P/S: 6.55
P/FCF: 23.18
P/B: 12.42
EV/EBITDA: 21.07

Growth

Rev 1Y: 15.60%

Income Statement (TTM)

Revenue: $4.97B
Gross Margin: 62.47%
Operating Expenses: $1.97B
Operating Income: $1.14B
Net Profit: $999.7M

Balance Sheet

Rev 1Y Fwd Est

12.19%

Rev 3Y (CAGR)

17.01%

Rev 5Y (CAGR)

19.33%

Rev 10Y (CAGR)

27.77%

EPS 1Y

47.18%

EPS 1Y Fwd Est

27.64%

EPS 3Y (CAGR)

37.73%

EPS 5Y (CAGR)

10.48%

EPS 10Y (CAGR)

—

Cash and Equivalents: $1.11B
Working Capital: $1.73B
Total Assets: $6.46B
Net Debt: $293.4M
Total Liabilities: $3.83B
Total Equity: $2.62B

Cash Flow Statement (TTM)

Cash Flow from Operations: $1.75B
Cash Flow from Investing: $530.7M
Cash Flow from Financing: -$2.33B
Free Cash Flow: $1.41B
Capital Expenditures: $343.7M